A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients With Lupus Nephritis (ZL-1103-013)
Clinical trial NCT05810948 · COMPLETED
Trial details
- NCT number
- NCT05810948
- Sponsor
- argenx
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-21
- Primary completion
- 2025-07-02
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.